15075188|t|Increased expression and apical targeting of renal ENaC subunits in puromycin aminonucleoside-induced nephrotic syndrome in rats.
15075188|a|Nephrotic syndrome is often accompanied by sodium retention and generalized edema. However, the molecular basis for the decreased renal sodium excretion remains undefined. We hypothesized that epithelial Na channel (ENaC) subunit dysregulation may be responsible for the increased sodium retention. An experimental group of rats was treated with puromycin aminonucleoside (PAN; 180 mg/kg iv), whereas the control group received only vehicle. After 7 days, PAN treatment induced significant proteinuria, hypoalbuminemia, decreased urinary sodium excretion, and extensive ascites. The protein abundance of alpha-ENaC and beta-ENaC was increased in the inner stripe of the outer medulla (ISOM) and in the inner medulla (IM) but was not altered in the cortex. gamma-ENaC abundance was increased in the cortex, ISOM, and IM. Immunoperoxidase brightfield- and laser-scanning confocal fluorescence microscopy demonstrated increased targeting of alpha-ENaC, beta-ENaC, and gamma-ENaC subunits to the apical plasma membrane in the distal convoluted tubule (DCT2), connecting tubule, and cortical and medullary collecting duct segments. Immunoelectron microscopy further revealed an increased labeling of alpha-ENaC in the apical plasma membrane of cortical collecting duct principal cells of PAN-treated rats, indicating enhanced apical targeting of alpha-ENaC subunits. In contrast, the protein abundances of Na(+)/H(+) exchanger type 3 (NHE3), Na(+)-K(+)-2Cl(-) cotransporter (BSC-1), and thiazide-sensitive Na(+)-Cl(-) cotransporter (TSC) were decreased. Moreover, the abundance of the alpha(1)-subunit of the Na-K-ATPase was decreased in the cortex and ISOM, but it remained unchanged in the IM. In conclusion, the increased or sustained expression of ENaC subunits combined with increased apical targeting in the DCT2, connecting tubule, and collecting duct are likely to play a role in the sodium retention associated with PAN-induced nephrotic syndrome. The decreased abundance of NHE3, BSC-1, TSC, and Na-K-ATPase may play a compensatory role to promote sodium excretion.
15075188	51	64	ENaC subunits	GeneOrGeneProduct	24767,24768,25122
15075188	68	93	puromycin aminonucleoside	ChemicalEntity	D011692
15075188	102	120	nephrotic syndrome	DiseaseOrPhenotypicFeature	D009404
15075188	124	128	rats	OrganismTaxon	10116
15075188	130	148	Nephrotic syndrome	DiseaseOrPhenotypicFeature	D009404
15075188	173	179	sodium	ChemicalEntity	D012964
15075188	206	211	edema	DiseaseOrPhenotypicFeature	D004487
15075188	266	272	sodium	ChemicalEntity	D012964
15075188	323	359	epithelial Na channel (ENaC) subunit	GeneOrGeneProduct	24767,24768,25122
15075188	411	417	sodium	ChemicalEntity	D012964
15075188	454	458	rats	OrganismTaxon	10116
15075188	476	501	puromycin aminonucleoside	ChemicalEntity	D011692
15075188	503	506	PAN	ChemicalEntity	D011692
15075188	586	589	PAN	ChemicalEntity	D011692
15075188	620	631	proteinuria	DiseaseOrPhenotypicFeature	D011507
15075188	633	648	hypoalbuminemia	DiseaseOrPhenotypicFeature	D034141
15075188	668	674	sodium	ChemicalEntity	D012964
15075188	700	707	ascites	DiseaseOrPhenotypicFeature	D001201
15075188	734	744	alpha-ENaC	GeneOrGeneProduct	25122
15075188	749	758	beta-ENaC	GeneOrGeneProduct	24767
15075188	886	896	gamma-ENaC	GeneOrGeneProduct	24768
15075188	1068	1078	alpha-ENaC	GeneOrGeneProduct	25122
15075188	1080	1089	beta-ENaC	GeneOrGeneProduct	24767
15075188	1095	1105	gamma-ENaC	GeneOrGeneProduct	24768
15075188	1325	1335	alpha-ENaC	GeneOrGeneProduct	25122
15075188	1413	1416	PAN	ChemicalEntity	D011692
15075188	1425	1429	rats	OrganismTaxon	10116
15075188	1471	1481	alpha-ENaC	GeneOrGeneProduct	25122
15075188	1531	1558	Na(+)/H(+) exchanger type 3	GeneOrGeneProduct	24784
15075188	1560	1564	NHE3	GeneOrGeneProduct	24784
15075188	1567	1598	Na(+)-K(+)-2Cl(-) cotransporter	GeneOrGeneProduct	25065
15075188	1600	1605	BSC-1	GeneOrGeneProduct	25065
15075188	1612	1656	thiazide-sensitive Na(+)-Cl(-) cotransporter	GeneOrGeneProduct	54300
15075188	1658	1661	TSC	GeneOrGeneProduct	54300
15075188	1710	1745	alpha(1)-subunit of the Na-K-ATPase	GeneOrGeneProduct	24211
15075188	1877	1890	ENaC subunits	GeneOrGeneProduct	24767,24768,25122
15075188	2017	2023	sodium	ChemicalEntity	D012964
15075188	2050	2053	PAN	ChemicalEntity	D011692
15075188	2062	2080	nephrotic syndrome	DiseaseOrPhenotypicFeature	D009404
15075188	2109	2113	NHE3	GeneOrGeneProduct	24784
15075188	2115	2120	BSC-1	GeneOrGeneProduct	25065
15075188	2122	2125	TSC	GeneOrGeneProduct	54300
15075188	2131	2142	Na-K-ATPase	GeneOrGeneProduct	24211
15075188	2183	2189	sodium	ChemicalEntity	D012964
15075188	Association	24211	D012964	Novel
15075188	Association	54300	D012964	Novel
15075188	Association	25065	D012964	Novel
15075188	Association	24784	D012964	Novel
15075188	Association	24768	D009404	Novel
15075188	Association	24767	D009404	Novel
15075188	Association	25122	D009404	Novel
15075188	Association	D012964	D009404	No
15075188	Negative_Correlation	D011692	54300	Novel
15075188	Negative_Correlation	D011692	25065	Novel
15075188	Negative_Correlation	D011692	24784	Novel
15075188	Positive_Correlation	D011692	24768	Novel
15075188	Positive_Correlation	D011692	24767	Novel
15075188	Positive_Correlation	D011692	25122	Novel
15075188	Negative_Correlation	D011692	D001201	Novel
15075188	Association	D011692	D012964	Novel
15075188	Positive_Correlation	D011692	D034141	Novel
15075188	Positive_Correlation	D011692	D011507	Novel
15075188	Positive_Correlation	D011692	D009404	No